Related Experiment Video
Updated: Dec 23, 2025

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
Published on: November 30, 2022
Therapeutic strategies for critically ill patients with COVID-19
Lei Li1, Ranran Li1, Zhixiong Wu2
1Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China.
Insights
Critical care for COVID-19 patients involves managing severe cases in the ICU. This summary outlines supportive strategies for respiratory and circulatory issues, organ function, and nutrition before specific treatments are available.
Area of Science:
- Critical care medicine
- Infectious diseases
- Virology
Background:
- The 2019 novel coronavirus (COVID-19) outbreak poses a global health threat.
- Critically ill COVID-19 patients require intensive management in the Intensive Care Unit (ICU), demanding significant medical resources.
Purpose of the Study:
- To summarize promising management strategies for COVID-19 patients in the ICU.
- To provide guidance on treatments before specific vaccines and drugs become available.
Main Methods:
- Reviewing previous experiences in treating other viral infections and influenza.
- Summarizing promising drugs and adjunctive agents.
- Detailing respiratory support, circulation management, and organ function monitoring.
- Outlining appropriate nutritional strategies.
Main Results:
- Identification of potential therapeutic drugs and supportive agents.
- Recommendations for respiratory and circulatory support.
- Emphasis on multi-organ function monitoring and nutritional support.
Conclusions:
- The summarized strategies offer a referable approach for managing severe COVID-19 in the ICU.
- These supportive measures are crucial in the interim period before the availability of specific COVID-19 vaccines and antiviral drugs.
Abstract:
Since the 2019 novel coronavirus disease (COVID-19) outbreak originated from Wuhan, Hubei Province, China, at the end of 2019, it has become a clinical threat to the general population worldwide. Among people infected with the novel coronavirus (2019-nCoV), the intensive management of the critically ill patients in intensive care unit (ICU) needs substantial medical resource. In the present article, we have summarized the promising drugs, adjunctive agents, respiratory supportive strategies, as well as circulation management, multiple organ function monitoring and appropriate nutritional strategies for the treatment of COVID-19 in the ICU based on the previous experience of treating other viral infections and influenza. These treatments are referable before the vaccine and specific drugs are available for COVID-19.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
09:06Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
Published on: December 12, 2025
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Heart Failure VI: Adjunct Therapies
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation